Table 6. Tanzania drug acquisition (in drug units,* FY Oct. 2010–Sept. 2011).** .
| Drug | Manufacturer | Donor/funder | Total needed | Total stock | Total funded | Gap |
| IVM tabs | Merck | Merck & Co. | 17,905,801 | 0 | 17,905,801 | 0 |
| ALB tabs (with IVM) | GSK/other | GSK | 7,034,422 | 0 | 7,034,422 | 0 |
| PZQ tabs | Multiple | USAID | 3,179,394 | 0 | 1,041,063 | 2,138,331 |
| TEO tubes | Multiple | 220,817 | 0 | 0 | 220,817 | |
| ZMAX POS bottles | Pfizer | ITI | 328,104 | 0 | 328,104 | 0 |
| ZMAX tabs | Pfizer | ITI | 13,331,922 | 0 | 13,331,922 | 0 |
* The tool also allowed users to display the monetary value of medicines, instead of the drug units.
** ALB = albendazole; GSK = GlaxoSmithKline; ITI = International Trachoma Initiative; IVM = ivermectin; POS = pediatric oral suspension; PZQ = praziquantel; TEO = tetracycline eye ointment; USAID = United States Agency for International Development; ZMAX = zithromax.